Texas House of Representatives · 90th Legislature, Regular Session
Official title: Relating to the effect of certain reductions in a health benefit plan enrollee's out-of-pocket expenses for prescription drugs that are essential health benefits on the enrollee's cost-sharing requirements.
Members who authored, joint-authored, or co-sponsored this bill.
SourceLegiScan (CC BY 4.0)90R
The bill amends Section 1369.0542 of the Insurance Code, which deals with reductions in a patient's out-of-pocket costs for prescription drugs. First, it limits the existing rule in that section to reductions made by or on behalf of an enrollee for a covered drug that has no generic equivalent or interchangeable biological product, or that the enrollee got through prior authorization, step therapy, or the plan issuer's exceptions and appeals process. Second, it adds a new requirement in Subsection (c). A health benefit plan issuer that covers prescription drugs, a pharmacy benefit manager, or a subcontractor shall apply any reduction in out-of-pocket expenses made on behalf of an enrollee to the enrollee's deductible, copayment, cost-sharing responsibility, or out-of-pocket maximum. This applies to a drug within a category of essential health benefits under 42 U.S.C. Section 18022(b)(1), even if the issuer, benefit manager, or subcontractor does not classify the drug as an essential health benefit. The bill defines a "subcontractor" as a person or entity, other than an employee of the plan issuer or pharmacy benefit manager, to whom either one delegates a function, activity, or service. The changes apply only to a plan delivered, issued for delivery, or renewed on or after January 1, 2028, and earlier plans stay under current law. The bill takes effect September 1, 2027, and its cost is not stated in the bill text.
Read the full text below for the definitive meaning.
Each version links to the authoritative document on capitol.texas.gov.
90R3395 RDS-D By: Jones of Dallas H.B. No. 1022 A BILL TO BE ENTITLED AN ACT relating to the effect of certain reductions in a health benefit plan enrollee's out-of-pocket expenses for prescription drugs that are essential health benefits on the enrollee's cost-sharing requirements. BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS: SECTION 1. Section 1369.0542, Insurance Code, is amended by
amending Subsection (a) and adding Subsection (c) to read as follows: (a) Subsection (b) [ This section ] applies only to a reduction in out-of-pocket expenses made by or on behalf of an enrollee for a prescription drug covered by the enrollee's health benefit plan for which: (1) a generic equivalent does not exist; (2) a generic equivalent does exist but the enrollee has obtained access to the prescription drug under the enrollee's health benefit plan using: (A) a prior authorization process; (B) a step therapy protocol; or (C) the health benefit plan issuer's exceptions and appeals process; (3) an interchangeable biological product does not exist; or (4) an interchangeable biological product does exist but the enrollee has obtained access to the prescription drug under the enrollee's health benefit plan using: (A) a prior authorization process; (B) a step therapy protocol; or (C) the health benefit plan issuer's exceptions and appeals process. (c) An issuer of a health benefit plan that covers prescription drugs, a pharmacy benefit manager, or a subcontractor shall apply any reduction in out-of-pocket expenses made on behalf of an enrollee for a prescription drug that is included within a category of essential health benefits under 42 U.S.C. Section 18022(b)(1), regardless of whether the health benefit plan issuer, pharmacy benefit manager, or subcontractor classifies the drug as an essential health benefit, to the enrollee's deductible, copayment, cost-sharing responsibility, or out-of-pocket maximum applicable to health benefits under the enrollee's plan. In this subsection, "subcontractor" means a person or entity, other than an employee of a health benefit plan issuer or pharmacy benefit manager, to whom the health benefit plan issuer or pharmacy benefit manager delegates the performance of a function, activity, or service. SECTION 2. Section 1369.0542, Insurance Code, as amended by this Act, applies only to a health benefit plan that is delivered, issued for delivery, or renewed on or after January 1, 2028. A health benefit plan delivered, issued for delivery, or renewed before January 1, 2028, is governed by the law as it existed immediately before the effective date of this Act, and that law is continued in effect for that purpose. SECTION 3. This Act takes effect September 1, 2027.
Each subject links to other 90R bills tagged the same way.
SourceLegiScan (CC BY 4.0)subject tags
SourceTexas Legislative Council (capitol.texas.gov)90R
No recorded roll-call votes on this bill.
SourceLegiScan (CC BY 4.0)90R
No fiscal notes or analyses recorded for this bill.
SourceLegiScan (CC BY 4.0)official fiscal notes & analyses (TLC)
Perch never collects comments itself — it points you to the Legislature's own hearing schedule and official public-comment channels (ADR-0007).
Official hearings & comment (capitol.texas.gov) →SourceTexas Legislative Council (capitol.texas.gov)official bill text (capitol.texas.gov)